~~<i id='BAF6D55A95'><strike id='BAF6D55A95'><tt id='BAF6D55A95'><pre id='BAF6D55A95'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：comprehensive 2025-08-17 00:02:28 - browse：3

Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy, is now a cautionary tale in pharmaceutical history.

This week Biogen said it would no longer sell or study the medicine, which first won approval in 2021, ending an era for one of biotech’s storied companies and leaving the rest of the industry to piece together the lessons of a would-be blockbuster that never took off.

STAT reporters took a stab at the Aduhelm legacy — for biotech, Biogen, and Alzheimer’s research — on a recent episode of the Readout LOUD. Here’s an edited transcript of that conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： People can get long Covid without testing positive for virus: Study

explore

Wikipedia

hotspot

explore

knowledge

AlexHogan/STATMEXICOCITY—Kellogg’siswagingawarhereoverTigreToñoandSamelTucán.A2019policyrequirescomp

WSS

Living with Hashimoto's and celiac disease, and med school, too

Listen: Vivek Ramaswamy's star turn & leaky drug data

Patient advocates sound warning on FDA proposal on salt intake

Trump's false claims about Georgia's 2020 election long debunked

FDA greenlights medical device to combat bladder issues

Cancer drug shortages' outsize impact on ovarian cancer patients

hotspot

fashion

explore

Psychedelics group wrestles with new pharma identity

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Health officials lay out plans to cope with respiratory virus season

Malaria cases in Florida and Texas: Here’s what you need to know

Former Pear Therapeutics executives start new VC firm

Hepatitis C has a cure — but many Americans still lack access to it

CDC says it’s too soon to assess risk posed by Covid subvariant

23andMe had bad news about my health. I wish a person had delivered it

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

explore

Cancer drug shortages' outsize impact on ovarian cancer patients

How the first Native Hawaiian psychiatrist helped diversify medicine

Trump's false claims about Georgia's 2020 election long debunked

FDA approves first treatment for ultra

PBMs are inflating the cost of generic drugs. They must be reined in

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Wikipedia

hotspot

explore

knowledge